Candesartan Cilexetil Tablet
Product Images NDC 62332-342

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Candesartan Cilexetil (NDC 62332-342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Candesartan 16 mg

Candesartan Cilexetil Tablets, USP 16 mg oral tablets packaging label. The label indicates 30 tablets per container, for prescription use only. It shows storage instructions, manufacturer details Alembic Pharmaceuticals Limited, and barcode with NDC 62332-343-30.*

FDA Label Image

Candesartan 4 mg

Packaging label for Candesartan Cilexetil Tablets, USP 4 mg, oral tablets by Alembic Pharmaceuticals Inc. The label shows NDC 62332-341-30, package of 30 tablets, storage instructions, and manufacturer details for Alembic Pharmaceuticals Limited, India and Alembic Pharmaceuticals, USA. It also includes a barcode and regulatory warnings.*

FDA Label Image

Candesartan 8 mg

Label for Candesartan Cilexetil Tablets USP 8 mg by Alembic Pharmaceuticals Inc. The label includes dosage form as tablets, quantity of 30 tablets, and storage instructions at 25°C with permitted excursions. It displays the NDC code 62332-342-30, barcode, and manufacturing details for Alembic Pharmaceuticals Limited in India and Alembic Pharmaceuticals Inc. in the USA.*

FDA Label Image

Candesartan Figure

A forest plot showing hazard ratios with 95% confidence intervals for different patient subgroups in a clinical study. The x-axis is labeled with hazard ratios from 0.4 to 1.3, indicating comparative effectiveness between Candesartan cilexetil and placebo. Subgroups include age, sex, race, NYHA class, LVEF, and various medical histories and medications. Each subgroup has a plotted point with horizontal lines representing confidence intervals, illustrating comparative outcomes for Candesartan cilexetil versus placebo in these groups.*

FDA Label Image

Structure (Candesartan Str)

Chemical structure diagram of the active ingredient Candesartan Cilexetil. The structure includes annotations indicating the site of ester hydrolysis.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.